Poster Abstracts • OFID 2019:6 (Suppl 2) • S471 Methods. A clinical pharmacist was hired to improve the quality of HIV care, both in the inpatient and outpatient setting. An electronic medical records alert was created for any patient with HIV who was admitted to the hospital. The clinical pharmacist then reviewed the ART orders Monday through Friday and provided recommendations to the inpatient teams. Data on the frequency and types of errors on the medication administration record (MAR) were recorded. Data were collected for 6 months, quality improvement purposes.
Virologic Failure in HIV-Infected Men Who Have Sex with Men and Transgender Women Treated in a Community-Based Model vs. a Hospital-based Model
Maximo O. Brito, MD, MPH; Shaveta Khosla, MPH; Supriya D. Mehta, MHS, PhD; Richard M. Novak, MD; University of Illinois at Chicago, Chicago, Illinois Session: 151. HIV: Care Continuum Friday, October 4, 2019: 12:15 PM Background. Men who have sex with men (MSM) and transgender women are disproportionately affected by HIV, especially those that belong to minority groups and lower socioeconomic status. The purpose of this study was to compare virologic failure in MSM and transgender women receiving HIV care at a community-based model (CBM) to a hospital-based model (HBM) of care.
Methods. This was a retrospective cohort study. We extracted data from electronic medical records of HIV-infected MSM and transgender women treated at one of the six community clinics or at a hospital-based clinic in Chicago between 2010 to 2014. The outcome was cumulative probability of virologic failure (i.e., viral load ≥200 copies/mL), measured in each semester of observation. We used multivariable Cox Proportional Hazards model to determine the association between CBM and HBM with virologic failure, adjusted for confounding variables.
Results. The sample consisted of 290 patients; of whom, 20 (7%) were transgender. Approximately half (49%) of the sample received care via CBM. Compared with patients receiving care at the HBM, CBM patients were more likely to be African American (72% vs. 61%), uninsured (50% vs. 39%) and with a history of substance abuse (38% vs. 24%). There was no difference in virologic failure between the two care models (57% in CBM vs. 52% in HBM; HR adj = 1.1; 95% CI: 0.8-1.6). Younger individuals (HR adj = 4.0; 95% CI: 2.3-7.1), alcohol users (HR adj = 1.6; 95% CI: 1.1-2.2) and patients without insurance (HR adj = 1.7; 95% CI: 1.1-2.6) were more likely to have virologic failure.
Conclusion. The CBM was as effective as a traditional HBM in providing care to MSM and transgender women despite their more marginalized status. Intensive outreach and targeted case management likely contributed to the effectiveness of this model and need further study.
Disclosures. All authors: No reported disclosures. Background. Patients with HIV (PWH) with sustained virologic suppression (VS) on antiretroviral therapy (ART) achieve better health outcomes and pose effectively no risk of transmitting HIV to their sexual contacts. Adherence to ART is the main predictor of VS in PWH, yet no adherence benchmark has been identified. The clinical utility of ART pharmacy refill history collection is unknown. We hypothesize that pharmacy refill histories of ART represented as a percentage of days covered (PDC) will correlate with VS in PWH.
The Association Between Refill History and Viral Load Suppression in HIVinfected Patients at a University-Based HIV Clinic in the Midwest
Methods. We conducted a single-center, retrospective cohort study of PWH ( ≥19 years) receiving care at a Midwestern HIV clinic between January 1, 2018 and December 31, 2018, with at least 1 HIV RNA reading during the study period. Refill histories were collected for each eligible study patient and a PDC was calculated as the "number of tablets dispensed / number of days within study period" to provide an ART coverage measure. ART regimen, sociodemographic, and clinical characteristics were abstracted from the HIV registry. An HIV RNA ≤ 50 copies/mL and a PDC of ≥80% were used as measures of VS and sufficient adherence, respectively. Pearson's chi-square tests and binary logistic regression were used to determine the effect of PDC on VS.
Results. A total of 1019 patients were included in the study. 705 (69%) patients had a PDC ≥80% and 314 (31%) had a PDC <80%. VS between groups was 96% (PDC ≥80%) vs. 74% (PDC < 80%). A significant association was observed between VS and PDC (P < 0.0001) [HJP1]. Patients with a PDC ≥80% were 9.5 times more likely to attain VS as compared with patients with PDC < 80% (95% CI, 5.89-15.17). After adjusting for ART regimen, sociodemographic, and other clinical characteristics, the likelihood of VS remained higher for patients with a PDC ≥ 80% (aOR: 6.3; 95% CI, 3.7-11.0). Factors found to be negatively associated with VS were single marital status (aOR: 0.49; 95% CI, 0.24-0.95), current or historical opportunistic infection (aOR: 0.51; 95% CI, 0.26-0.99), and usage of a multiclass or dual ART regimen (aOR: 0.40; 95% CI, 0.16-0.98).
Conclusion. The utilization of PDC as an ART adherence benchmark was significantly associated with VS. PDC is an easy measure to calculate and could be useful in the clinical care of PWH. Future prospective studies are needed to confirm these findings.
Disclosures. All authors: No reported disclosures. S472 • OFID 2019:6 (Suppl 2) • Poster Abstracts of this program, rapid-start initiation of antiretroviral therapy (ART) was not implemented prior to discharge. The purpose of this study was to evaluate the impact of a pharmacist-driven antiretroviral stewardship and transitions of care service in persons living with HIV/AIDS (PLWHA). Methods. This was a retrospective pre-and post-analysis of PLWHA hospitalized at University of Illinois Hospital (UIH). Patients included were adults following at UIH outpatient clinics for HIV care admitted to UIH for acute care. Data were collected between April 19, 2017 and October 19, 2017 for the pre-implementation phase, and between July 1, 2018 and December 31, 2018 for the post-implementation phase. The post-implementation phase included an HIV-trained clinical pharmacist (Figure 1 ). Primary and secondary endpoints included follow-up rates at UIH outpatient HIV clinics, 30-day readmission rates, and access to medications at hospital discharge. Statistical analysis included descriptive statistics and Fisher's Exact test.
Results. A total of 119 patients were included in the analysis, 66 in the pre-implementation phase and 53 in the post-implementation phase. Patients included were mostly black males with median age of 48. In the pre-implementation phase 50 out of 65 (77%) patients attended follow-up visits for HIV care at UIH outpatient clinics, vs. 42 out of 47 (89%) patients in the post-implementation phase (P = 0.1329). Thirty-day readmission occurred in 17 of 62 (27%) patients in the pre-implementation phase vs. 5 of 52 (10%) of patients in the post-implementation phase (P = 0.0183). During the post-implementation phase, the HIV pharmacist secured access of ART and opportunistic infection medications prior to discharge for 22 patients (42%), 2 of which were new diagnoses.
Conclusion. A pharmacist-led antiretroviral stewardship and TOC program led to a decrease in 30-day readmission rates in PLWHA. Although not significant, the HIV-pharmacist led to higher rates of clinic follow-up. Finally, the HIV-pharmacist helped secure access to ART and initiate rapid-start therapy in newly diagnosed patients prior to leaving the hospital.
Disclosures. All authors:
No reported disclosures. Friday, October 4, 2019: 12:15 PM Background. The United States has the largest incarcerated population in the world with 6.61 million adults in 2016. 1 While incarceration is a known risk factor for difficulties in linkage to care 2-3 and adverse health outcomes 4-6 , little is published on post-release incarcerated persons living with HIV (PLWH) in Florida.
The Impact of Recent Incarceration on
Methods. Data were acquired from the Florida Cohort, an ongoing, longitudinal, cross-sectional study of PLWH recruited across HIV clinics in the state of Florida, from 2014 to 2018. Chi-square and multiple regression analyses correlated recent incarceration (within last 12 months) with demographics, HIV care adherence, perceived barriers to care, and self-reported high-risk behaviors.
Results. Of 936 participants, 6.4% (n = 60) reported recent incarceration within the last 12 months. Those recently incarcerated were more likely to report missing at least one appointment in the last 6 months (46.7% vs. 22.2%; P < 0.0001), to have an excessively long travel time ( >60 minutes) to a HIV provider (34.5% vs. 16.6%, P = 0.002; OR 2.66 [95% CI: 1.20-5.92]), and to lack reliable transportation (70% vs. 47.5%, P = 0.0007; OR 1.70 [95% CI: 0.82-3.52]) Those not recently incarcerated reported having completed a high school education (OR: 0.69 [95% CI: 0.5-0.97]) and stated they "never missed an appointment" (OR: 0.42 [95% CI: 0.22-0.81]). Recently incarcerated PLWH also had higher occurrence of high-risk behaviors such as receiving (40.4% vs. 8.7%; P = 0.001) or providing (30.4% vs. 10.4%; P = 0.000) money or drugs for sex, having used IV drugs (15% vs. 4%; P = 0.001), and not using condoms during exchange of drugs for sex (OR: 9.43 [95% CI: 3.78-23.52]).
Conclusion. Recently incarcerated PLWH continue to have significant geographical and logistical barriers to care and self-report more high-risk behaviors than nonincarcerated peers. Enhanced case management and telehealth services may be useful in linkage to care when PLWH transition from correctional to community healthcare systems in the Florida setting.
